6-46704644-C-A

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_005084.4(PLA2G7):​c.1242G>T​(p.Glu414Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0006 in 1,577,884 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00060 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00060 ( 0 hom. )

Consequence

PLA2G7
NM_005084.4 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.05

Publications

7 publications found
Variant links:
Genes affected
PLA2G7 (HGNC:9040): (phospholipase A2 group VII) The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency. Two transcript variants encoding the same protein have been found for this gene.[provided by RefSeq, Dec 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01131922).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLA2G7NM_005084.4 linkc.1242G>T p.Glu414Asp missense_variant Exon 12 of 12 ENST00000274793.12 NP_005075.3 Q13093
PLA2G7NM_001168357.2 linkc.1242G>T p.Glu414Asp missense_variant Exon 12 of 12 NP_001161829.1 Q13093
PLA2G7XM_005249408.5 linkc.1242G>T p.Glu414Asp missense_variant Exon 12 of 12 XP_005249465.1 Q13093
PLA2G7XM_047419359.1 linkc.1107G>T p.Glu369Asp missense_variant Exon 11 of 11 XP_047275315.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLA2G7ENST00000274793.12 linkc.1242G>T p.Glu414Asp missense_variant Exon 12 of 12 1 NM_005084.4 ENSP00000274793.7 Q13093
PLA2G7ENST00000537365.1 linkc.1242G>T p.Glu414Asp missense_variant Exon 12 of 12 1 ENSP00000445666.1 Q13093

Frequencies

GnomAD3 genomes
AF:
0.000605
AC:
92
AN:
152074
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00203
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000897
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000526
AC:
132
AN:
250988
AF XY:
0.000494
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00136
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000687
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000599
AC:
854
AN:
1425692
Hom.:
0
Cov.:
27
AF XY:
0.000568
AC XY:
404
AN XY:
711720
show subpopulations
African (AFR)
AF:
0.0000912
AC:
3
AN:
32878
American (AMR)
AF:
0.00135
AC:
60
AN:
44590
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25922
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39466
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85598
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53372
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5716
European-Non Finnish (NFE)
AF:
0.000698
AC:
753
AN:
1078960
Other (OTH)
AF:
0.000625
AC:
37
AN:
59190
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
39
78
118
157
196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000605
AC:
92
AN:
152192
Hom.:
0
Cov.:
31
AF XY:
0.000618
AC XY:
46
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41514
American (AMR)
AF:
0.00203
AC:
31
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000897
AC:
61
AN:
68000
Other (OTH)
AF:
0.00
AC:
0
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000670
Hom.:
0
Bravo
AF:
0.000597
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.000437
AC:
53
EpiCase
AF:
0.00104
EpiControl
AF:
0.000830

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 01, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: PLA2G7 c.1242G>T (p.Glu414Asp) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00053 in 250988 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in PLA2G7 causing Platelet-Activating Factor Acetylhydrolase Deficiency, allowing no conclusion about variant significance. To our knowledge, no occurrence of c.1242G>T in individuals affected with Platelet-Activating Factor Acetylhydrolase Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as uncertain significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
1.5
DANN
Benign
0.55
DEOGEN2
Benign
0.052
T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.073
N
LIST_S2
Benign
0.18
.;T
M_CAP
Benign
0.0094
T
MetaRNN
Benign
0.011
T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.39
N;N
PhyloP100
-1.1
PrimateAI
Benign
0.20
T
PROVEAN
Benign
-0.040
N;N
REVEL
Benign
0.090
Sift
Benign
0.47
T;T
Sift4G
Benign
0.62
T;T
Polyphen
0.0
B;B
Vest4
0.093
MutPred
0.54
Loss of disorder (P = 0.277);Loss of disorder (P = 0.277);
MVP
0.24
MPC
0.0051
ClinPred
0.0091
T
GERP RS
-5.9
Varity_R
0.16
gMVP
0.33
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145290218; hg19: chr6-46672381; API